HomeNews

News

Rosselkhoznadzor has received authority to issue veterinary EAEU GMP certificates

In Russia, the legal framework for issuing EAEU GMP certificates to veterinary medicine manufacturers has been finalized. The Russian Government published Resolution No. 295...

Russian Innovations for Export: Rheumatoid Arthritis Drug Enters the Vietnamese Market

The R-Pharm Group, which develops advanced medicines in Pushchino near Moscow, is introducing its proprietary rheumatoid arthritis therapy to the pharmaceutical market of the...

New Horizons in SMA Treatment: Promomed Launches Large-Scale Study Based on Risdiplam

Pharmaceutical company Promomed, together with leading specialized experts, has initiated a unique clinical study that could radically change approaches to treating spinal muscular atrophy...

Cancer-Fighting Probiotics: Scientists Turn Bacteria into Living Drug Factories Inside Tumors

Researchers from Shandong University have modified probiotic bacteria for targeted drug delivery to solid tumors. According to a study published on March 17, 2026,...

Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease

On March 6, 2026, Japan's Ministry of Health, Labour and Welfare announced the conditional approval of Amchepry (raguneprocel). This is the world's first commercially...

IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets

Contract research organization Charles River Laboratories has signed agreements to sell several of its divisions. The European early-stage drug development assets (Discovery Services) will...
spot_img

Expert Articles

spot_img